2:41 PM
 | 
Jul 30, 2018
 |  BC Extra  |  Preclinical News

Apelin is a potential sarcopenia therapeutic

A paper in Nature Medicine suggests that apelin (APLN) could help treat sarcopenia as well as serve as a biomarker of the age-related disease characterized by skeletal muscle loss.

Researchers from University of Toulouse and colleagues first observed that plasma APLN levels were reduced in a cohort of elderly patients with age-related loss of muscle in the...

Read the full 267 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >